Physician

Alexis Bashinski Shaefer, M.D.

According to 2025 Medicare claims, Alexis Shaefer, M.D. (NPI: 1942590872) practices neurology in the Augusta-Richmond County, GA-SC market, with the plurality of this provider's patient population coming from Richmond, GA. This provider's primary affiliated billing organization is NEUROLOGICAL ASSSOCIATE OF AUGUSTA, PC (NPI: 1437167137; TIN: 582527154) and primary practice location at 30909-1812.

Shaefer's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 841 traditional Medicare patients, billed 20,887 HCPCS/CPT codes, and received $269,320 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 2,973 prescription claims across 475 beneficiaries totaling $1,093,339 in drug costs, led by Gamunex-C (Immune Globul G/Gly/Iga Avg 46). 2023 DME data shows 11 claims. Open Payments data shows 255 records totaling $47,811. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $4,231 to $269,320. Similarly, Part D prescription costs have moved sharply higher in recent years, from $19,836 to $1,093,339. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $245 to $641.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	39	51	$4,231
2016	181	1,080	$52,912
2017	361	6,722	$121,471
2018	444	8,207	$143,268
2019	514	17,915	$203,485
2020	481	18,391	$171,880
2021	629	20,161	$252,442
2022	775	21,098	$284,601
2023	845	21,101	$282,859
2024	841	20,887	$269,320

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	22	98	$19,836
2016	55	208	$18,207
2017	123	771	$71,715
2018	187	1,161	$387,246
2019	275	1,797	$603,027
2020	308	2,027	$539,060
2021	411	2,226	$685,164
2022	424	2,078	$646,372
2023	420	2,572	$920,265
2024	475	2,973	$1,093,339

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	12	$245
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	11	$140
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	112	112	$136
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	112	127	$127
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	607	903	$82
95886	Needle measurement of electrical activity in arm or leg muscles, complete study	100	124	$67
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	228	332	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Gamunex-C	Immune Globul G/Gly/Iga Avg 46	12	336	$131,707
Betaseron	Interferon Beta-1b	11	308	$101,702
Rytary	Carbidopa/Levodopa	28	2,150	$70,770
Ubrelvy	Ubrogepant	45	1,335	$58,367
Briviact	Brivaracetam	18	900	$44,188

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	255	$47,811	Takeda Pharmaceuticals U.S.A., Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Alexis Bashinski Shaefer, M.D.?

Tedicare shows public-source Medicare data for Alexis Bashinski Shaefer, M.D. (NPI 1942590872), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alexis Bashinski Shaefer, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Alexis Bashinski Shaefer, M.D.?

Alexis Bashinski Shaefer, M.D. is linked to NEUROLOGICAL ASSSOCIATE OF AUGUSTA, PC (billing NPI 1437167137) in the available physician profile data.

Does Alexis Bashinski Shaefer, M.D. have Open Payments data?

Alexis Bashinski Shaefer, M.D. has 255 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.